Login Register Cart 0
Generic placeholder image

Central Nervous System Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5249
ISSN (Online): 1875-6166

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Capparis spinosa Promoted BDNF and Antioxidant Enzyme Levels to Protect Against Learning and Memory Deficits Induced by Scopolamine

Author(s): Mahmoud Hosseini, Fatemeh Mansouritorghabeh, Farimah Beheshti, Fatemeh Shahidpour, Fatemeh Forouzanfar and Arezoo Rajabian*

Volume 23, Issue 2, 2023

Published on: 09 August, 2023

Page: [109 - 118] Pages: 10

DOI: 10.2174/1871524923666230719121439

Price: $65

Abstract

Background: Alzheimer's disease (AD) is a major neurodegenerative disorder with multiple manifestations, including oxidative stress, brain-derived neurotrophic factor (BDNF) depletion, and cholinergic dysfunction. Capparis spinosa (C. spinosa) is identified as a potential source of nutrition for alleviating various ailments. The current study assessed the ameliorating properties of C. spinosa hydroethanolic extract on memory dysfunction and the possible roles of oxidative stress and BDNF in the scopolamine (Scop)-treated rats.

Methods: Forty male Wistar rats were divided into the following four groups: Control, Scop (2 mg/kg, intraperitoneal injection (i.p.)), Scop + C. spinosa 150, and Scop + C. spinosa 300 groups. The rats were given C. spinosa extract (150 or 300 mg/kg, oral) for 3 weeks. During the third week, Passive Avoidance (PA) and Morris Water Maze (MWM) tests were done to assess memory and learning performance. Finally, oxidative stress markers and BDNF in the brain tissue were evaluated.

Results: Scop injection was associated with a significant increase in the time latency and travelled distance to reach the platform during the learning phase of MWM In the probe test, the Scoptreated rats showed a lower time and distance in the target area. Furthermore, Scop injection significantly decreased the latency to enter the dark while increasing the dark time and the frequency of entries to the dark zone of the PA task. C. spinosa extract effectively reversed the behavioural changes induced by Scop. Treatment with the extract also significantly increased the levels of superoxide dismutase, catalase, thiols, and BDNF, while decreasing malondialdehyde production in the brains of the Scop-injured rats.

Conclusion: C. spinosa hydroethanolic extract successfully ameliorated Scop-induced memory impairment by modifying BDNF and oxidative stress markers in the brain of amnesic rats.

Next »
Graphical Abstract

[1]
Rajashri K, Mudhol S, Serva Peddha M, Borse BB. Neuroprotective effect of spice oleoresins on memory and cognitive impairment associated with scopolamine-induced alzheimer’s disease in rats. ACS Omega 2020; 5(48): 30898-905.
[http://dx.doi.org/10.1021/acsomega.0c03689] [PMID: 33324798]
[2]
Abdel-Latif MS, Abady MMA, Saleh SR, Abdel-Monaem N, Ghareeb DA. Effect of berberine and ipriflavone mixture against scopolamine-induced alzheimer-like disease. Int J Pharm Phytopharmacol Res 2019; 9(3): 48-63.
[3]
Aykac A, Ozbeyli D, Uncu M. et al. Evaluation of the protective effect of Myrtus communis in scopolamine-induced Alzheimer model through cholinergic receptors. Gene 2019; 689: 194-201.
[http://dx.doi.org/10.1016/j.gene.2018.12.007] [PMID: 30553998]
[4]
Tönnies E, Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer’s disease. J Alzheimers Dis 2017; 57(4): 1105-21.
[http://dx.doi.org/10.3233/JAD-161088] [PMID: 28059794]
[5]
Nieto RR, Carrasco A, Corral S. et al. BDNF as a biomarker of cognition in schizophrenia/psychosis: An updated review. Front Psychiatry 2021; 12: 662407.
[http://dx.doi.org/10.3389/fpsyt.2021.662407] [PMID: 34220575]
[6]
Goshtasbi H, Pakchin PS, Movafeghi A. et al. Impacts of oxidants and antioxidants on the emergence and progression of Alzheimer’s disease. Neurochem Int 2022; 153: 105268.
[http://dx.doi.org/10.1016/j.neuint.2021.105268] [PMID: 34954260]
[7]
Annaz H, Sane Y, Bitchagno GTM. et al. Caper (Capparis spinosa L.): An updated review on its phytochemistry, nutritional value, traditional uses, and therapeutic potential. Front Pharmacol 2022; 13: 878749.
[http://dx.doi.org/10.3389/fphar.2022.878749] [PMID: 35935860]
[8]
Sun Y, Yang T, Wang C. Capparis spinosa L. as a potential source of nutrition and its health benefits in foods: A comprehensive review of its phytochemistry, bioactivities, safety, and application. Food Chem 2023; 409: 135258.
[http://dx.doi.org/10.1016/j.foodchem.2022.135258] [PMID: 36587515]
[9]
Nabavi SF, Maggi F, Daglia M, Habtemariam S, Rastrelli L, Nabavi SM. Pharmacological effects of Capparis spinosa L. Phytother Res 2016; 30(11): 1733-44.
[http://dx.doi.org/10.1002/ptr.5684] [PMID: 27406313]
[10]
Zhang H, Ma Z. Phytochemical and pharmacological properties of Capparis spinosa as a medicinal plant. Nutrients 2018; 10(2): 116.
[http://dx.doi.org/10.3390/nu10020116] [PMID: 29364841]
[11]
Baradaran Rahimi V, Rajabian A, Rajabi H. et al. The effects of hydro-ethanolic extract of Capparis spinosa (C. spinosa) on lipopolysaccharide (LPS)-induced inflammation and cognitive impairment: Evidence from in vivo and in vitro studies. J Ethnopharmacol 2020; 256: 112706.
[http://dx.doi.org/10.1016/j.jep.2020.112706] [PMID: 32109547]
[12]
Turgut NH, Kara H. Arslanbaş E, Mert DG, Tepe B, Güngör H. Effect of Capparis spinosa L. on cognitive impairment induced by D-galactosein mice via inhibition of oxidative stress. Turk J Med Sci 2015; 45(5): 1127-36.
[http://dx.doi.org/10.3906/sag-1405-95] [PMID: 26738358]
[13]
Ali ZN, Eddouks M, Michel JB, Sulpice T, Hajji L. Cardiovascular effect of Capparis spinosa aqueous extract. part III: Antihypertensive effect in spontaneously hypertensive rats. Am J Pharmacol Toxicol 2007; 2(3): 111-5.
[http://dx.doi.org/10.3844/ajptsp.2007.111.115]
[14]
Hosseini Z, Mansouritorghabeh F, Kakhki FSH. et al. Effect of Sanguisorba minor on scopolamine-induced memory loss in rat: Involvement of oxidative stress and acetylcholinesterase. Metab Brain Dis 2022; 37(2): 473-88.
[http://dx.doi.org/10.1007/s11011-021-00898-y] [PMID: 34982352]
[15]
Gacar N, Mutlu O, Utkan T, Komsuoglu Celikyurt I, Gocmez SS, Ulak G. Beneficial effects of resveratrol on scopolamine but not mecamylamine induced memory impairment in the passive avoidance and Morris water maze tests in rats. Pharmacol Biochem Behav 2011; 99(3): 316-23.
[http://dx.doi.org/10.1016/j.pbb.2011.05.017] [PMID: 21624386]
[16]
Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-6.
[http://dx.doi.org/10.1016/S0076-6879(84)05016-3] [PMID: 6727660]
[17]
Baghcheghi Y, Beheshti F, Salmani H, Hosseini M. Brain-derived neurotrophic factor and nitric oxide contribute to protective effects of rosiglitazone on learning and memory in hypothyroid rats. Acta Neurobiol Exp 2021; 81(3): 218-32.
[http://dx.doi.org/10.21307/ane-2021-021] [PMID: 34672293]
[18]
Lim D, Son H, Um M. et al. Enhanced cognitive effects of demethoxycurcumin, a natural derivative of curcumin on scopolamine-induced memory impairment in mice. Molecules 2016; 21(8): 1022.
[http://dx.doi.org/10.3390/molecules21081022] [PMID: 27527139]
[19]
Goel A. Digvijaya, Garg A, Kumar A. Effect of Capparis spinosa Linn. extract on lipopolysaccharide-induced cognitive impairment in rats. Indian J Exp Biol 2016; 54(2): 126-32.
[PMID: 26934780]
[20]
Mayne K, White JA, McMurran CE, Rivera FJ, de la Fuente AG. Aging and neurodegenerative disease: Is the adaptive immune system a friend or foe? Front Aging Neurosci 2020; 12: 572090.
[http://dx.doi.org/10.3389/fnagi.2020.572090] [PMID: 33173502]
[21]
Niedzielska E, Smaga I, Gawlik M. et al. Oxidative stress in neurodegenerative diseases. Mol Neurobiol 2016; 53(6): 4094-125.
[http://dx.doi.org/10.1007/s12035-015-9337-5] [PMID: 26198567]
[22]
Lancour D, Dupuis J, Mayeux R. et al. Analysis of brain region-specific co-expression networks reveals clustering of established and novel genes associated with Alzheimer disease. Alzheimers Res Ther 2020; 12(1): 103.
[http://dx.doi.org/10.1186/s13195-020-00674-7] [PMID: 32878640]
[23]
Chhatwal JP, Sperling RA. Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease. J Alzheimers Dis 2012; 31(Suppl 3(0 3)): S155-167.
[http://dx.doi.org/10.3233/JAD-2012-120730]
[24]
Beheshti F, Hashemzehi M, Sabeti N, Hashemi Sadr S, Hosseini M. The effects of aminoguanidine on hippocampal cytokines, amyloid beta, brain-derived neurotrophic factor, memory and oxidative stress status in chronically lipopolysaccharide-treated rats. Cytokine 2019; 113: 347-55.
[http://dx.doi.org/10.1016/j.cyto.2018.10.005] [PMID: 30327173]
[25]
Aksoz E, Gocmez SS, Sahin TD, Aksit D, Aksit H, Utkan T. The protective effect of metformin in scopolamine-induced learning and memory impairment in rats. Pharmacol Rep 2019; 71(5): 818-25.
[http://dx.doi.org/10.1016/j.pharep.2019.04.015] [PMID: 31382167]
[26]
Mohebali N, Shahzadeh Fazeli SA, Ghafoori H. et al. Effect of flavonoids rich extract of Capparis spinosa on inflammatory involved genes in amyloid-beta peptide injected rat model of Alzheimer’s disease. Nutr Neurosci 2018; 21(2): 143-50.
[http://dx.doi.org/10.1080/1028415X.2016.1238026] [PMID: 27778760]
[27]
Foudah AI, Devi S, Alam A, Salkini MA, Ross SA. Anticholinergic effect of resveratrol with vitamin E on scopolamine-induced Alzheimer’s disease in rats: Mechanistic approach to prevent inflammation. Front Pharmacol 2023; 14: 1115721.
[http://dx.doi.org/10.3389/fphar.2023.1115721] [PMID: 36817151]
[28]
Chen BH, Park JH, Lee TK. et al. Melatonin attenuates scopolamine-induced cognitive impairment via protecting against demyelination through BDNF-TrkB signaling in the mouse dentate gyrus. Chem Biol Interact 2018; 285: 8-13.
[http://dx.doi.org/10.1016/j.cbi.2018.02.023] [PMID: 29476728]
[29]
Beheshti F, Akbari HR, Baghcheghi Y, Mansouritorghabeh F, Mortazavi Sani SS, Hosseini M. Beneficial effects of angiotensin converting enzyme inhibition on scopolamine-induced learning and memory impairment in rats, the roles of brain-derived neurotrophic factor, nitric oxide and neuroinflammation. Clin Exp Hypertens 2021; 43(6): 505-15.
[http://dx.doi.org/10.1080/10641963.2021.1901112] [PMID: 33724113]
[30]
Lv J, Lu C, Jiang N. et al. Protective effect of ginsenoside Rh2 on scopolamine‐induced memory deficits through regulation of cholinergic transmission, oxidative stress and the ERK‐CREB‐BDNF signaling pathway. Phytother Res 2021; 35(1): 337-45.
[http://dx.doi.org/10.1002/ptr.6804] [PMID: 32754961]
[31]
Kim SK, Kwon DA, Kim YS, Lee HS, Kim HK, Kim WK. Standardized extract (HemoHIM) protects against scopolamine-induced amnesia in a murine model. Evid Based Complement Alternat Med 2021; 2021: 1-11.
[http://dx.doi.org/10.1155/2021/8884243] [PMID: 33815562]
[32]
Meddour A, Yahia M, Hambaba L. Safety evaluation and analgesic studies of defatted methanol extract of Capparis spinosa L. (Capparidaceae) fruits and roots bark in albino wistar rats. J Biol Res 2019; 92(1): 7456.
[http://dx.doi.org/10.4081/jbr.2019.7456]
[33]
Fallah Huseini H, Hasani-Rnjbar S, Nayebi N. et al. Capparis spinosa L. (Caper) fruit extract in treatment of type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Complement Ther Med 2013; 21(5): 447-52.
[http://dx.doi.org/10.1016/j.ctim.2013.07.003] [PMID: 24050578]
[34]
Sakrani I, Ameddah S, Benrebaia M. et al. Algerian Capparis spinosa n-buoh extract alleviates diabetic neuropathy induced with streptozotocin in rats. Egypt J Chem 2022; 65(13): 519-38.
[35]
Heidari M, Mirshamsi M, Naghibi B, Heidari M, Vafazade J, Heidari M. Evaluation of hepatotoxicity and renal toxicity of methanolic extract of capparis spinosa in rats. JSSU 2010; 18(1): 47-55.
[36]
El-Hawary SS, Taha KF, Kirillos FN, Dahab AA, El-Mahis AA, El-Sayed SH. Complementary effect of Capparis spinosa L. and silymarin with/without praziquantel on mice experimentally infected with Schistosoma mansoni. Helminthologia 2018; 55(1): 21-32.
[http://dx.doi.org/10.1515/helm-2017-0055] [PMID: 31662624]
[37]
Sini KR, Sinha BN, Rajasekaran A. Protective effects of Capparis zeylanica linn. Leaf extract on gastric lesions in experimental animals. Avicenna J Med Biotechnol 2011; 3(1): 31-5.
[PMID: 23407576]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy